Details for New Drug Application (NDA): 204886
✉ Email this page to a colleague
NDA 204886 describes ZONTIVITY, which is a drug marketed by Key Therap and is included in one NDA. There are two patents protecting this drug. Additional details are available on the ZONTIVITY profile page.
The generic ingredient in ZONTIVITY is vorapaxar sulfate. Additional details are available on the vorapaxar sulfate profile page.
The generic ingredient in ZONTIVITY is vorapaxar sulfate. Additional details are available on the vorapaxar sulfate profile page.
Summary for 204886
| Tradename: | ZONTIVITY |
| Applicant: | Key Therap |
| Ingredient: | vorapaxar sulfate |
| Patents: | 2 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 204886
Generic Entry Date for 204886*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 2.08MG BASE | ||||
| Approval Date: | May 8, 2014 | TE: | RLD: | Yes | |||||
| Patent: | 7,304,078 | Patent Expiration: | Dec 23, 2027 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
| Patented Use: | REDUCTION OF THROMBOTIC CARDIOVASCULAR EVENTS | ||||||||
| Patent: | 7,713,999 | Patent Expiration: | May 30, 2024 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
| Patented Use: | REDUCTION OF THROMBOTIC CARDIOVASCULAR EVENTS IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION (MI) OR WITH PERIPHERAL ARTERIAL DISEASE (PAD) | ||||||||
Expired US Patents for NDA 204886
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Key Therap | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | 7,235,567 | ⤷ Subscribe |
| Key Therap | ZONTIVITY | vorapaxar sulfate | TABLET;ORAL | 204886-001 | May 8, 2014 | 7,713,999 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
